Objective: To evaluate the role of talcum powder use as a risk factor for t
he development of epithelial ovarian cancer.
Methods: In a case-control study, 499 patients with epithelial ovarian canc
er were frequency matched for age at diagnosis (+/-5 years) with a control
population of 755 patients. The odds ratio (OR) for the development of epit
helial ovarian cancer was estimated using logistic regression analysis with
adjustment for age at diagnosis, parity, oral contraceptive use, smoking h
istory, family history of epithelial ovarian cancer, age at menarche, menop
ausal status, income, education, geographic location, history of tubal liga
tion, and previous hysterectomy.
Results: Two hundred twenty-one of 462 patients (47.89%) in the study popul
ation and 311 of 693 patients (44.9%) in the control population had ever us
ed talcum powder (OR 0.92; 95% confidence interval [CI] 0.24, 3.62). A sign
ificant association between duration of talc use and development of epithel
ial ovarian cancer was not demonstrable for 1-9 years (OR 0.9; 95% CI 0.6,
1.5), for 10-19 years (OR 1.4; 95% CI 0.9, 2.2), or for more than 20 years
(OR 0.9; 95% CI 0.6, 1.2). To eliminate the possible confounding variable o
f surgery for the management of ovarian cancer, we omitted 135 patients in
the study population who underwent hysterectomy within 5 years of the diagn
osis of ovarian cancer. Within this subgroup of patients, tubal ligation or
hysterectomy among talc users still failed to demonstrate an increased ris
k for the development of ovarian cancer (OR 0.9; 95% CI 0.4, 2.2).
Conclusion: A significant association between the use of talcum powder and
the risk of developing epithelial ovarian cancer is not demonstrable, even
with prolonged exposure. (C) 1999 by The American College of Obstetricians
and Gynecologists.